Skip to main content
Back
Watch Compare

IR-Med, Inc.

Data quality: 83%
IRME
OTC Manufacturing Measuring & Analyzing Instruments
$0.01
▲ $0.00 (37.25%)
Mkt Cap: 768,670.0
Price
$0.01
Mkt Cap
768,670.0
Day Range
$0.05 — $0.05
52-Week Range
$0.00 — $0.45
Volume
594
Open $0.05
50D / 200D Avg
$0.00
288.89% above
50D / 200D Avg
$0.03
72.11% below

Quick Summary

Key Takeaways

Negative free cash flow of -839,000.0

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.12
Interest Coverage-488.00

Valuation

PE (TTM)
-0.33
Above sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.3 -1.5
P/B — 1.6
ROE % — -53.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -2.35 M
ROE N/A ROA -1571.91%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -839,000.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.12
Interest Coverage -488.00 Asset Turnover N/A
Working Capital -684,000 Tangible Book Value -625,000
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.33 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -109.15%
Market Cap 768,670.0 Enterprise Value 705,670.0
Per Share
EPS (Diluted TTM) -0.04 Revenue / Share N/A
FCF / Share -0.01 OCF / Share -0.01
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 35.70%
SBC-Adj. FCF -1.38 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Revenue — — — —
Net Income -1.90 M -4.91 M -4.73 M -3.72 M
EPS (Diluted) -0.03 -0.07 — —
Gross Profit — — — —
Operating Income -1.94 M -4.91 M -4.76 M -3.68 M
EBITDA — — — —
R&D Expenses 710,000.0 2.06 M 1.89 M 1.42 M
SG&A Expenses — — — —
D&A — — — —
Interest Expense -3,000.0 20,000.0 — —
Income Tax — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021
Total Assets 251,000.0 999,000.0 3.29 M 2.94 M
Total Liabilities 545,000.0 634,000.0 702,000.0 572,000.0
Shareholders' Equity -294,000.0 365,000.0 2.59 M 2.37 M
Total Debt — — — —
Cash & Equivalents 129,000.0 767,000.0 3.00 M 2.82 M
Current Assets 205,000.0 848,000.0 3.06 M 2.88 M
Current Liabilities 545,000.0 473,000.0 662,000.0 —